創世紀(300083.SZ):五軸加工中心等高端數控機牀是現階段積極培育的種子產品
格隆匯7月18日丨創世紀(300083.SZ)近期接受特定對象調研時表示,五軸加工中心等高端數控機牀是公司現階段積極培育的種子產品,發展目標是提高公司產品附加值,穩步攻佔高端市場,實現國產替代,在製造業轉型升級中培育新的增長點。
公司目前有五軸聯動立式加工中心、五軸聯動龍門加工中心等10多款五軸聯動機牀,已實現小批量量產。未來,公司將根據不同行業的應用場景,持續投入,提升五軸高端數控機牀的銷售數量,逐步實現進口替代的目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.